ZimVie Inc. (ZIMV)

Market Cap	535.72M +23.1%
Revenue (ttm)	443.40M -2.2%
Net Income	-19.47M
EPS	-0.70
Shares Out	28.21M
PE Ratio	n/a
Forward PE	21.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	653,573
Open	18.99
Previous Close	n/a
Day's Range	18.99 - 19.00
52-Week Range	8.15 - 19.01
Beta	2.06
Analysts	Hold
Price Target	14.50 (-23.64%)
Earnings Date	Oct 29, 2025

About ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 1,770
• Stock Exchange: NASDAQ
• Ticker Symbol: ZIMV
• Website: https://www.zimvie.com

Financial Performance

In 2024, ZimVie's revenue was $449.75 million, a decrease of -1.68% compared to the previous year's $457.43 million. Losses were -$25.83 million, -93.43% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for ZIMV stock is "Hold." The 12-month stock price target is $14.5, which is a decrease of -23.64% from the latest price.

Price Target

$14.5

(-23.64% downside)

Analyst Consensus: Hold